The thymus is a complex organ responsible for the maturation and education of peripheral T cells. Production of broadly reactive T cells and maintenance of a diverse peripheral T cell repertoire are critical to the success of the human immune system. Unfortunately, thymopoiesis is attenuated by normal aging. As an individual ages, the thymus involutes by unknown mechanisms and output of new T cells significantly falls. Loss of a broadly reactive naive peripheral T cell repertoire with age results in suppressed immune responses to infections and vaccines in adults. Moreover, when the adult peripheral T cell pool is damaged by viral infection (HIV), chemotherapy, or irradiation, there is a need to therapeutically reconstitute the periphery with new T cells. The functional status of the aged thymus dictates quantity and quality of T cell reconstitution and immunity. Thymic involution is an ordered process resulting in induction of thymocyte apoptosis. It has recently been demonstrated that IL-6 gene family cytokines are elevated in aged human and mouse thymus tissue, and that they actively suppress thymopoiesis in mice. These observations have lead to the hypothesis that age-induced thymic involution is an active process mediated by thymosuppressive cytokines. The overall goal of this proposal is to define critical factors and pathways involved in thymus tissue aging, and be poised to translate newly-defined therapeutic strategies to humans for improved immunity in a variety of clinical settings in adults. The proposed specific aims to accomplish this goal are to determine the mechanisms by which Leukemia Inhibitory Factor and other thymosuppressive cytokines induce thymus involution by defining cytokine and steroid production pathways that result in thymocyte depletion throughout aging, to determine if inhibition of Leukemia Inhibitory Factor and other thymosuppressive cytokines can prevent or reverse thymic atrophy of aging in mice, and to determine if improved thymic function in aged mice can enhance peripheral immune responses to infectious pathogens or vaccines.
| Szabolcs, Paul; Buckley, Rebecca H; Davis, Robert Duane et al. (2015) Tolerance and immunity after sequential lung and bone marrow transplantation from an unrelated cadaveric donor. J Allergy Clin Immunol 135:567-70 |
| Lynch, Heather E; Sempowski, Gregory D (2013) Molecular measurement of T cell receptor excision circles. Methods Mol Biol 979:147-59 |
| Ventevogel, Melissa S; Sempowski, Gregory D (2013) Thymic rejuvenation and aging. Curr Opin Immunol 25:516-22 |
| Chinn, Ivan K; Blackburn, Clare C; Manley, Nancy R et al. (2012) Changes in primary lymphoid organs with aging. Semin Immunol 24:309-20 |
| Shi, Xin; Zhang, Ping; Sempowski, Gregory D et al. (2011) Thymopoietic and bone marrow response to murine Pneumocystis pneumonia. Infect Immun 79:2031-42 |
| Billard, Matthew J; Gruver, Amanda L; Sempowski, Gregory D (2011) Acute endotoxin-induced thymic atrophy is characterized by intrathymic inflammatory and wound healing responses. PLoS One 6:e17940 |
| Pastva, Amy M; Mukherjee, Sambuddho; Giamberardino, Charles et al. (2011) Lung effector memory and activated CD4+ T cells display enhanced proliferation in surfactant protein A-deficient mice during allergen-mediated inflammation. J Immunol 186:2842-9 |
| Gruver, Amanda L; Ventevogel, Melissa S; Sempowski, Gregory D (2009) Leptin receptor is expressed in thymus medulla and leptin protects against thymic remodeling during endotoxemia-induced thymus involution. J Endocrinol 203:75-85 |
| Lynch, Heather E; Goldberg, Gabrielle L; Chidgey, Ann et al. (2009) Thymic involution and immune reconstitution. Trends Immunol 30:366-73 |
| Gruver, Amanda L; Sempowski, Gregory D (2008) Cytokines, leptin, and stress-induced thymic atrophy. J Leukoc Biol 84:915-23 |
Showing the most recent 10 out of 13 publications
